Optos plc (Optos) is a medical technology company engaged in the design, development, manufacture and marketing of ultra wide field and high resolution images retinal imaging devices for early detection of ophthalmic conditions like retinal detachment, glaucoma, cataracts, retinal holes/retinal tears and age-related macular degeneration. The company offers a wide range of medical devices that support different customer segments and patient levels. Its technology provides an unequalled combination of wide-field retinal imaging for the practitioner and patient resulting in more targeted treatment regimes. The company has operations in the US, Canada, Germany, Switzerland, Norway, Sweden, Spain and France. Optos is headquartered in Scotland, the UK.